The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so the first thing people tried was let's make Inhibitors of that enzyme so we can boost this natural gp1 signal and those are improved uh uh uh diabetes drugs they're called gpon you've probably heard about them Genovia is the most common one and those boost the level of gp1 the natural glp1 in the in the produced from the intestine by about three-fold and they're effective in treating diabetes not people lose weight people do not lose weight
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.